Ki-67 overexpression for risk stratification of early dysplasia in Barrett’s esophagus: Friend or foe?
Diseases of the Esophagus · 2023
DOI: 10.1093/dote/doac079 ↗Kurz gefasst
Editorial in der Zeitschrift Diseases of the Esophagus, 2023. Verfasst von Madhav Desai. Beteiligte Einrichtung: Department of Gastroenterology, Kansas City VA Medical Center, Kansas City, MO, USA. Hauptthemen laut MEDLINE: Barrett Esophagus, Esophageal Neoplasms, Precancerous Conditions. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Kansas City VA Medical Center, Kansas City, MO, USA.
ORCID-Profile: Madhav Desai
Zitieren
APA
Desai, M. (2023). Ki-67 overexpression for risk stratification of early dysplasia in Barrett’s esophagus: Friend or foe?. Diseases of the Esophagus. https://doi.org/10.1093/dote/doac079
Vancouver
Desai M. Ki-67 overexpression for risk stratification of early dysplasia in Barrett’s esophagus: Friend or foe?. Diseases of the Esophagus. 2023. doi:10.1093/dote/doac079
BibTeX
@article{Desai2023,
author = {Desai, Madhav},
title = {Ki-67 overexpression for risk stratification of early dysplasia in Barrett’s esophagus: Friend or foe?},
journal = {Diseases of the Esophagus},
year = {2023},
doi = {10.1093/dote/doac079}
}
EUVIMED